BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1708234)

  • 1. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK; Gonias SL
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
    Hall SW; Humphries JE; Gonias SL
    J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
    Gonias SL; Figler NL; Braud LL
    Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK; Wolf B; Gonias SL
    Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.
    Gonias SL; Figler NL
    Biochem J; 1988 Oct; 255(2):725-30. PubMed ID: 2462416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human plasmin with human alpha 2-macroglobulin.
    Cummings HS; Castellino FJ
    Biochemistry; 1984 Jan; 23(1):105-11. PubMed ID: 6197993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K; Léránt I; Tenekejiev K; Machovich R
    J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasmin by fibrinogen.
    Higazi AA; Mayer M
    Biochem J; 1990 Jul; 269(2):299-302. PubMed ID: 2143650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
    Humphries JE; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1993 Jan; 13(1):48-55. PubMed ID: 7678497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Matsuo O; Collen D
    Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.
    Anonick PK; Vetter WH; Gonias SL
    Biochem J; 1989 Dec; 264(3):745-52. PubMed ID: 2482733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN; Cercek B; Lew AS; Ganz W
    Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M; Brufatto N; Neill E; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.